Anavex Life Sciences Investor Presentation, 12 Oct 2017
Missling, C. U., Afshar, M. & Perry, G. Investor Presentation: Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Patients. Anavex Life Sci. Invest. Present. Anavex Life Sci. Invest. Present. (2017).